InsidersTradesSigma
Follow the 澳华内镜 share price and the full directors' dealings record of the company, a listed issuer based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 澳华内镜 has recorded 5 public disclosures. Market capitalisation: €3.4bn. The latest transaction was disclosed on 16 December 2025 (Sale). Among the most active insiders: 顾小舟. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
澳华内镜是一家专业从事医疗器械，特别是内窥镜的开发和制造的公司。该公司在上海证券交易所上市。